Trending
Most Popular
U.S. Stocks Propel Forward On Monday – February 9, 2026 -( $AVGO $DV $FLYX $META $NOK $NVDA $OKLO $OPEN $ORCL $PLTR $RIO $TSLA $TSM Rise!)
US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the…
by John F. Heerdink, Jr. February 10, 2026
Dow Breaks 50,000 as Wall Street Limps, Then Leaps Into the Weekend – February 6, 2026 -( $DIA $EPRX $FLYX $LLY $MCD $MANE $MODD $NOK $RIO Rise!)
Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after…
by John F. Heerdink, Jr. February 6, 2026
Agriculture & Energy
Google Buys Its Own Sunshine: Inside the $4.75 Billion Intersect Power Deal -( $GOOG $GOOGL )
Alphabet’s decision to acquire Intersect Power for roughly $4.75 billion is less a vanity green purchase…
by John F. Heerdink, Jr. 3 hours ago
From Benicia to the Bahamas: The Surprising Supply Chain Behind California’s Gas Spike -( $PSX $VLO )
California drivers are discovering that “California premium” at the pump comes with a 40‑cent surprise this…
by John F. Heerdink, Jr. February 16, 2026
Meta’s $10 Billion Indiana Data Bet: When AI Meets the Corn Belt -( $META )
Meta’s decision to plant a more-than-1-gigawatt data center in Lebanon, Indiana, reads like a statement that…
by John F. Heerdink, Jr. February 12, 2026
Biotech & Healthcare
Gene Editing’s Next Act: How A Nobel Laureate Wants To Turn CRISPR From Hype To Habit
In an era when artificial intelligence has stolen most of biotech’s buzz, gene editing is quietly…
by John F. Heerdink, Jr. 16 minutes ago
Gilead’s $7.8 Billion Bet on Arcellx: When CAR‑T Goes Prime Time for Multiple Myeloma -( $ACLX $GLD $XBI $IBB )
Gilead Sciences (GLD) is paying up to $7.8 billion to acquire Arcellx (ACLX) , a…
by John F. Heerdink, Jr. 3 hours ago
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
by John F. Heerdink, Jr. 14 hours ago
Consumer Goods & Trends
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
by John F. Heerdink, Jr. 4 days ago
Carvana’s Earnings Hit a Speed Bump: Record Sales, Market Throws On the Parking Brake -( $CVNA $SPY )
Carvana’s (CVNA) latest earnings report delivered record sales and solid profits, but Wall Street still sent…
by John F. Heerdink, Jr. 5 days ago
The Big Mac Meets the Skinny Pill: How McDonald’s and Eli Lilly Are Sharing the Same Consumer -( $LLY $MCD )
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but…
by John F. Heerdink, Jr. February 12, 2026
Financials & Fintech
Earnings, Algorithms, PCE and Iran: What Could Possibly Go Wrong? -( $DIA $QQQ $SPY $VIX )
Wall Street closed Thursday walking a now-familiar tightrope: cheering resilient earnings and AI-fueled innovation while eyeing…
by John F. Heerdink, Jr. 4 days ago
How 2026 Turns Savers Into Shoppers in the New Banking Economy For Gen Z & Beyond
The coming year in banking looks surprisingly upbeat for savers who are willing to click, compare,…
by Vista Partners LLC December 28, 2025
Steve Ballmer’s Intuit Dome Unveiled: $2 Billion HQ Redefines Sports Arenas and Corporate Campuses -( $INTU $MSFT $SPY )
Intuit’s (INTU) latest splash isn’t in fintech, but in construction—where the budget now garners more buzz…
by Vista Partners LLC November 18, 2025
Investing & Inspiration
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
by John F. Heerdink, Jr. 14 hours ago
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
by John F. Heerdink, Jr. 3 days ago
Healthcare’s Favorite Scrub Maker Is Quietly Stitching a Bigger Future for FIGS
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that…
by John F. Heerdink, Jr. 4 days ago
Materials & Natural Resources
Critical Minerals, Critical Money: How Japan and M2i–Volato Aim to Cash In on a $320 Billion Market -( $MTWO $SOAR )
Japan is about to become one of America’s biggest energy backers, wiring in a $36 billion…
by John F. Heerdink, Jr. February 18, 2026
Corning and Meta’s $6 Billion Fiber Tie-Up: AI’s New Glass Half Full -( $AMZN $GLW $META $NVDA $GOOG $MSFT )
Corning (GLW) and Meta (META) just inked a multiyear, up to $6 billion agreement that effectively…
by John F. Heerdink, Jr. January 27, 2026
Gold’s Best Week in Years and Silver’s Dash Toward $100: Is This the Start of a New Metals Supercycle? -( $GLD $SLV )
Gold just logged its best week since 2020 while silver flirted with triple digits, turning the…
by John F. Heerdink, Jr. January 23, 2026
Technology & Beyond
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
by John F. Heerdink, Jr. 14 hours ago
February 20, 2026- Tariffs, Tantrums, and a 1.1% Gain: Wall Street’s Surprisingly Chill Week -( $EPRX $NOK $NVDA $OPEN Rise!)
US stocks finished the holiday‑shortened week ended Friday, February 20, 2026 higher, as a landmark Supreme…
by John F. Heerdink, Jr. 3 days ago
February 19, 2026- Soft Landing, Hard Reality: What Today’s Sell‑Off Is Whispering to Patient Investors -( $DV $INTG $MODD $MTWO $NOK $OPEN $SER $VIX Rise!)
U.S. stocks traded lower on Thursday, with major indexes pulling back after recent gains as investors…
by John F. Heerdink, Jr. 4 days ago
Latest News
Gene Editing’s Next Act: How A Nobel Laureate Wants To Turn CRISPR From Hype To Habit
In an era when artificial intelligence has stolen most of biotech’s buzz, gene editing is quietly…
by John F. Heerdink, Jr. 16 minutes ago
Gilead’s $7.8 Billion Bet on Arcellx: When CAR‑T Goes Prime Time for Multiple Myeloma -( $ACLX $GLD $XBI $IBB )
Gilead Sciences (GLD) is paying up to $7.8 billion to acquire Arcellx (ACLX) , a…
by John F. Heerdink, Jr. 3 hours ago
Google Buys Its Own Sunshine: Inside the $4.75 Billion Intersect Power Deal -( $GOOG $GOOGL )
Alphabet’s decision to acquire Intersect Power for roughly $4.75 billion is less a vanity green purchase…
by John F. Heerdink, Jr. 3 hours ago
Must-Watch Videos
Most Read
Featured
Varda Space Aims to Turn Low Earth Orbit into Pharma’s New Production Line
The new space economy is quietly adding an unexpected aisle to the drugstore: a “made‑in‑orbit” shelf…
by John F. Heerdink, Jr. 14 hours ago
Eupraxia’s Latest Raise: A Diffusphere-Fueled War Chest Aims at GI Disease -( $EPRX $IBB $XBI $SNY)
In a market that has grown wary of “story stocks,” Eupraxia Pharmaceuticals (NASDAQ: EPRX) just delivered…
by John F. Heerdink, Jr. 3 days ago
Amazon’s Amazing Theatrical Expansion – $AMZN $SPY
Amazon has unveiled ambitious plans to significantly increase its theatrical movie releases starting in 2025, aiming…
by John F. Heerdink, Jr. April 3, 2025
Lawrence Summers Warns of Economic Storm Clouds Ahead – $SPY $QQQ $DIA $VIX
Former Treasury Secretary Lawrence Summers has delivered a sobering outlook for the U.S. economy, suggesting that…
by John F. Heerdink, Jr. April 8, 2025
